AIM: To create a coronary heart disease (CHD) risk prediction model specific to type 1 diabetes. METHODS: Development of the model used data from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). EDC subjects had type 1 diabetes diagnosed between 1950 and 1980, received their first study exam between 1986 and 1988, and have been followed biennially since. The final cohort for model development consisted of 603 subjects and 46 incident events. Hard CHD was defined as CHD death, fatal/non-fatal MI or Q-waves. Baseline CHD risk factors were tested bivariately and introduced into a Weibull model. The prediction model was externally validated in the EURODIAB Prospective Complications Study. RESULTS: In males, predictors were higher white blood cell count, micro- or macroalbuminuira, lower HDLc and longer diabetes duration. In females, larger waist/hip ratio, higher non-HDLc, higher systolic blood pressure, use of blood pressure medication, and longer diabetes duration were included. Models were robust to internal and external validation procedures. CONCLUSIONS: CHD risk prediction models for hard CHD in those with type 1 diabetes should include risk factors not considered by existing models. Using models specifically developed for predicting CHD in type 1 diabetes may allow for more targeted prevention strategies. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
AIM: To create a coronary heart disease (CHD) risk prediction model specific to type 1 diabetes. METHODS: Development of the model used data from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). EDC subjects had type 1 diabetes diagnosed between 1950 and 1980, received their first study exam between 1986 and 1988, and have been followed biennially since. The final cohort for model development consisted of 603 subjects and 46 incident events. Hard CHD was defined as CHD death, fatal/non-fatal MI or Q-waves. Baseline CHD risk factors were tested bivariately and introduced into a Weibull model. The prediction model was externally validated in the EURODIAB Prospective Complications Study. RESULTS: In males, predictors were higher white blood cell count, micro- or macroalbuminuira, lower HDLc and longer diabetes duration. In females, larger waist/hip ratio, higher non-HDLc, higher systolic blood pressure, use of blood pressure medication, and longer diabetes duration were included. Models were robust to internal and external validation procedures. CONCLUSIONS: CHD risk prediction models for hard CHD in those with type 1 diabetes should include risk factors not considered by existing models. Using models specifically developed for predicting CHD in type 1 diabetes may allow for more targeted prevention strategies. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Authors: Jinan B Saaddine; Michael M Engelgau; Gloria L Beckles; Edward W Gregg; Theodore J Thompson; K M Venkat Narayan Journal: Ann Intern Med Date: 2002-04-16 Impact factor: 25.391
Authors: J S Dorman; R E Laporte; L H Kuller; K J Cruickshanks; T J Orchard; D K Wagener; D J Becker; D E Cavender; A L Drash Journal: Diabetes Date: 1984-03 Impact factor: 9.461
Authors: Sabita S Soedamah-Muthu; Nish Chaturvedi; Monika Toeller; Barry Ferriss; Paolo Reboldi; Georges Michel; Christos Manes; John H Fuller Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: A S Krolewski; E J Kosinski; J H Warram; O S Leland; E J Busick; A C Asmal; L I Rand; A R Christlieb; R F Bradley; C R Kahn Journal: Am J Cardiol Date: 1987-04-01 Impact factor: 2.778
Authors: Sabita S Soedamah-Muthu; Yvonne Vergouwe; Tina Costacou; Rachel G Miller; Janice Zgibor; Nish Chaturvedi; Janet K Snell-Bergeon; David M Maahs; Marian Rewers; Carol Forsblom; Valma Harjutsalo; Per-Henrik Groop; John H Fuller; Karel G M Moons; Trevor J Orchard Journal: Diabetologia Date: 2014-09-04 Impact factor: 10.122
Authors: Jingchuan Guo; Maria M Brooks; Matthew F Muldoon; Ashely I Naimi; Trevor J Orchard; Tina Costacou Journal: Diabetes Care Date: 2019-06-27 Impact factor: 19.112
Authors: Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel Journal: Diabetes Care Date: 2014-08-11 Impact factor: 19.112
Authors: Elsayed Z Soliman; Jye-Yu C Backlund; Ionut Bebu; Trevor J Orchard; Bernard Zinman; John M Lachin Journal: Diabetes Care Date: 2017-03-16 Impact factor: 19.112
Authors: Johnny W Bai; Geneviève Boulet; Elise M Halpern; Leif E Lovblom; Devrim Eldelekli; Hillary A Keenan; Michael Brent; Narinder Paul; Vera Bril; David Z I Cherney; Alanna Weisman; Bruce A Perkins Journal: Cardiovasc Diabetol Date: 2016-01-25 Impact factor: 9.951